The commissioner, Dr. Margaret A. Hamburg, said that clinical trials had shown that the drug was not helping breast cancer patients to live longer or to meaningfully control their tumors, but did expose them to potentially serious side effects like severe high blood pressure and hemorrhaging ...
Related News:-
F.D.A. Plans to Revoke Approval for Breast Cancer Drug
The Food and Drug Administration said on Thursday that it would move to revoke approval of the widely used drug Avastin as a treatment for breast cancer because the ...
Panel Urges F.D.A. to Revoke Approval of Drug for Breast Cancer ...
The 12-to-1 vote represents a stinging setback for Avastin, which is now the world’s best-selling cancer drug, with global sales of about $6 billion last year. The ...
Panel Advises F.D.A. to Narrow Its Approval for Avastin
In a series of 6-0 votes, an advisory committee to the F.D.A. endorsed the agency’s proposal to revoke the approval of the drug for use against advanced breast cancer.
F.D.A. Panel Urges Limits for Avastin
An advisory committee recommended revoking federal approval of the drug as a treatment for breast cancer.
Genentech to Appeal to F.D.A. for Breast Cancer Drug
{The New York Times News via BioPortfolio} Genentech will ask the F.D.A. to rethink its proposal to revoke the approval of Avastin for breast cancer on the grou...
Bevacizumab - Wikipedia, the free encyclopedia
Bevacizumab (trade name Avastin, Genentech/Roche) is a drug that blocks angiogenesis, the growth of new blood vessels. It is commonly used to treat various cancers, including ...
Breast Cancer Drug Avastin Will Still Be Paid By Medicare | ThirdAge
Breast cancer drug Avastin will still be paid for by Medicare, even if the FDA revokes the drug’s approval as a treatment for that disease.
Genentech to Appeal to F.D.A. for Breast Cancer Drug ...
BioScreening news and events ... Avian Influenza Frequently Asked Questions; Bird Flu Facts; Bird Flu History
FDA Grants Hearing to Genentech on Avastin June 28-29, 2011 ...
February 24, 2011, 4:23 pm F.D.A. Grants Hearing on Avastin as Treatment for Breast Cancer By ANDREW POLLACK The Food and Drug Administration has granted a hearing for ...
No comments:
Post a Comment